"From routine appointments to emergency services, it’s important to get the care you need—when you need it. But we understand you may be delaying your health needs over concerns about safety. At Mount Sinai, our doctors, nurses, and staff members are working continuously to ensure your safety so that you don't have to put your health on hold."

During the past decade, Mount Sinai Union Square conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 23 clinical trials were completed, i.e. on average, 88.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 14 clinical trials were completed. i.e. 127.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mount Sinai Union Square" #1 sponsor was "National Cancer Institute (NCI)" with 27 trials, followed by "Icahn School of Medicine at Mount Sinai" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "Gynecologic Oncology Group" with 3 trials sponsored and "NRG Oncology" with 3 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mount Sinai Union Square" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Mount Sinai Union Square" are "Breast Adenocarcinoma" (4 trials), "Invasive Breast Carcinoma" (4 trials), "Stage IIIA Breast Cancer" (4 trials), "Stage IV Breast Cancer AJCC v6 and v7" (4 trials) and "Endometrial Clear Cell Adenocarcinoma" (3 trials). Many other conditions were trialed in "Mount Sinai Union Square" in a lesser frequency.

Most popular intervention types in "Mount Sinai Union Square" are "Drug" (44 trials), "Other" (39 trials), "Biological" (16 trials), "Radiation" (14 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (25 trials), "Quality-of-Life Assessment" (16 trials), "Paclitaxel" (11 trials), "Carboplatin" (10 trials) and "Cisplatin" (10 trials). Other intervention names were less common.

The vast majority of trials in "Mount Sinai Union Square" are 42 trials for "All" genders, 12 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Mount Sinai Union Square". undefined are not yet recruiting, 10 are recruiting, 30 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in Mount Sinai Union Square, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Mount Sinai Union Square, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".